查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1339168

肌肉鬆弛劑市場、份額、規模、趨勢、產業分析報告：按藥物類型、給藥途徑、分銷管道、地區和細分市場預測，2023-2032 年

Muscle Relaxant Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs); By Route of Administration; By Distribution Channel; By Region, And Segment Forecasts, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球肌肉鬆弛劑市場規模預計將達到 56.7 億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

人們對肌肉鬆弛劑及其益處的認識不斷提高，給藥技術的進步預計也將推動市場成長。 此外，越來越多地使用包括肌肉鬆弛劑在內的聯合療法作為治療方案的一部分，預計也將推動未來幾年的市場成長。 此外，以較低價格提供通用肌肉鬆弛劑預計也將推動市場成長，特別是在新興國家。

與工作相關的肌肉骨骼疾病是醫護人員的常見問題，而腰痛是最常被通報的投訴之一。 這突顯出需要有效的治療方法（例如肌肉鬆弛劑）來控制這些症狀並改善受影響者的生活品質。 因此，對此類藥物的需求可能會增加，為市場創造成長機會。

除了 FDA 核准的藥物外，還有超適應症用於治療痙攣和肌肉痙攣的肌肉鬆弛劑，例如苯二氮平類藥物、加巴噴丁類藥物和鴉片類藥物。 然而，這些藥物具有很高的副作用風險，並且有可能被濫用，因此不建議在這些情況下使用它們。 重要的是，醫療保健專業人員仔細評估每種藥物的風險和益處，並根據個別患者的需求量身定制治療方案。

副作用是使用肌肉鬆弛劑的重要問題。 這些症狀包括嗜睡、頭暈、意識混亂、口乾和視力模糊。 這些副作用可能很嚴重，甚至危及生命，並可能限制該行業的發展。 因此，平衡這些藥物的益處和潛在風險並根據具體情況仔細評估其使用至關重要。

肌肉鬆弛劑市場報告亮點

由於肌肉骨骼疾病的增加和聯合療法的創新，骨骼鬆弛劑領域佔據了最大份額。

由於高處方率和口腔產品的可用性，口腔細分市場擁有很大的市場份額。

由於擁有熟練的醫生和護士以及有效的治療選擇，酒店業預計將佔據更大的銷售份額。

由於存在專門的醫療保健基礎設施，預計北美在研究期間將會成長。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球肌鬆藥市場洞察

  • 肌肉鬆弛劑市場 - 通路概況
  • 肌肉鬆弛劑市場動態
    • 推動者和機會
      • 老年人口增加
      • 肌肉骨骼疾病的盛行率不斷上升
    • 抑制因素和挑戰
      • 肌肉鬆弛劑的副作用
  • PESTEL 分析
  • 肌鬆藥市場通路的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球肌肉鬆弛劑市場（依藥物類型）

  • 主要發現
  • 簡介
  • 骨骼肌鬆弛劑
  • 臉部肌肉鬆弛劑
  • 神經肌肉阻斷劑

第 6 章全球肌肉鬆弛劑市場（依給藥途徑）

  • 主要發現
  • 簡介
  • 口頭
  • 注射劑

第 7 章全球肌肉鬆弛劑市場（依通路）

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 診斷實驗室

第 8 章全球肌肉鬆弛劑市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年肌肉鬆弛劑市場評估（按地區）
  • 肌肉鬆弛劑市場 - 北美
    • 北美：肌肉鬆弛劑市場，依藥物類型，2019-2032 年
    • 北美：肌肉鬆弛劑市場，依通路劃分，2019-2032 年
    • 北美：肌肉鬆弛劑市場（依給藥途徑），2019-2032 年
    • 肌肉鬆弛劑市場 - 美國
    • 肌肉鬆弛劑市場 - 加拿大
  • 肌肉鬆弛劑市場 - 歐洲
    • 歐洲：肌肉鬆弛劑市場（以藥物類型），2019-2032 年
    • 歐洲：肌肉鬆弛藥物市場，依通路劃分，2019-2032 年
    • 歐洲：肌肉鬆弛劑市場（依給藥途徑），2019-2032 年
    • 肌肉鬆弛劑市場 - 英國
    • 肌肉鬆弛劑市場 - 法國
    • 肌肉鬆弛劑市場 - 德國
    • 肌肉鬆弛劑市場 - 義大利
    • 肌肉鬆弛劑市場 - 西班牙
    • 肌肉鬆弛劑市場 - 荷蘭
    • 肌肉鬆弛劑市場 - 俄羅斯
  • 肌肉鬆弛劑市場 - 亞太地區
    • 亞太地區：肌肉鬆弛劑市場，依藥物類型，2019-2032 年
    • 亞太地區：肌肉鬆弛藥物市場，依通路劃分，2019-2032 年
    • 亞太地區：肌肉鬆弛劑市場（依給藥途徑），2019-2032 年
    • 肌肉鬆弛劑市場 - 中國
    • 肌肉鬆弛劑市場 - 印度
    • 肌肉鬆弛劑市場 - 馬來西亞
    • 肌肉鬆弛劑市場－日本
    • 肌肉鬆弛劑市場 - 印度尼西亞
    • 肌肉鬆弛劑市場－韓國
  • 肌肉鬆弛劑市場 - 中東和非洲
    • 中東和非洲：肌肉鬆弛藥物市場（按藥物類型），2019-2032 年
    • 中東和非洲：2019-2032 年肌肉鬆弛藥物市場（按分銷管道）
    • 中東和非洲：肌肉鬆弛劑市場（依給藥途徑），2019-2032 年
    • 肌肉鬆弛劑市場－沙烏地阿拉伯
    • 肌肉鬆弛劑市場 - 阿拉伯聯合大公國
    • 肌肉鬆弛劑市場 - 以色列
    • 肌肉鬆弛劑市場 - 南非
  • 肌肉鬆弛劑市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年肌肉鬆弛藥物市場（依藥物類型）
    • 拉丁美洲：肌肉鬆弛藥物市場，依通路劃分，2019-2032 年
    • 拉丁美洲：肌肉鬆弛劑市場，依給藥途徑劃分，2019-2032 年
    • 肌肉鬆弛劑市場 - 墨西哥
    • 肌肉鬆弛劑市場 - 巴西
    • 肌肉鬆弛劑市場－阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • Amneal Pharmaceuticals
  • Ipsen Biopharmaceuticals
  • Merz Pharmaceuticals
  • Par Pharmaceutical
  • Endo Pharmaceuticals
  • Vertical Pharmaceuticals
  • Mallinckrodt
  • SteriMax
  • Eisai Co.
  • Metacel Pharmaceuticals
  • Metacel Pharmaceuticals
Product Code: PM3548

The global muscle relaxant drugs market size is expected to reach USD 5.67 billion by 2032, according to a new study by Polaris Market Research. The report "Muscle Relaxant Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs); By Route of Administration; By Distribution Channel; By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Growing awareness about muscle relaxant drugs and their benefits, along with advancements in drug delivery technologies, are also expected to drive market growth. The increasing use of combination therapies that include muscle relaxants as a part of the treatment regimen is also expected to propel market growth in the coming years. Furthermore, the availability of generic versions of muscle relaxants at lower prices is expected to drive market growth, particularly in emerging economies.

Work-related musculoskeletal disorders are a common issue among healthcare workers, and lower back pain is one of the most frequently reported complaints. This highlights the need for effective treatments, such as muscle relaxant drugs, to manage these conditions and improve the quality of life for affected individuals. As a result, the demand for such drugs is likely to increase, which could provide growth opportunities for the market.

In addition to the FDA-approved drugs, there are also other muscle relaxant medications used off-label for spasticity or muscle spasms, including benzodiazepines, gabapentinoids, and opioids. However, their use for these conditions is not recommended as they have a higher risk of adverse effects and abuse potential. It is important for healthcare professionals to carefully evaluate the risks and benefits of each medication and tailor the treatment to the individual patient's needs.

Side effects are a significant concern associated with the use of muscle relaxants. It includes drowsiness, dizziness, confusion, dry mouth, and blurred vision. These side effects can be severe and, in some cases, even life-threatening, which can limit the growth of the industry. Therefore, it is crucial to balance the benefits of these drugs against the potential risks and carefully evaluate their use on a case-by-case basis.

Muscle Relaxant Drugs Market Report Highlights

Skeletal relaxant segment held the largest share, owing to rise in musculo-skeletal disorders, and innovation in combination therapies.

Oral segment accounted for the larger market share owing to their high prescription rate, and availability in products in oral form

Hospital segment is projected to experience larger revenue share, due to the presence skilled doctors and nurses, and effective treatment options

North America is expected to grow over the study period, due to presence of dedicated healthcare infrastructure

The global players include: Amneal Pharmaceuticals, Ipsen Biopharmaceuticals, Merz Pharmaceuticals, Par Pharmaceutical, Endo Pharmaceuticals, Vertical Pharmaceuticals, Mallinckrodt, SteriMax, Eisai Co., Metacel Pharmaceuticals, and Teva Pharmaceuticals.

Polaris Market Research has segmented the muscle relaxant drugs market report based on drug type, route of administration, distribution channel, and region:

Muscle Relaxant Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Skeletal Muscle Relaxant Drugs
  • Facial Muscle Relaxant Drugs
  • Neuromuscular Blocking Agents

Muscle Relaxant Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Injectable

Muscle Relaxant Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Diagnostic Labs

Muscle Relaxant Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Distribution Channels
    • 3.2.1. Primary Distribution Channels
    • 3.2.2. Secondary Distribution Channels

4. Global Muscle Relaxant Drugs Market Insights

  • 4.1. Muscle Relaxant Drugs Market - Distribution Channel Snapshot
  • 4.2. Muscle Relaxant Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing geriatric population
      • 4.2.1.2. Increasing prevalence of musculoskeletal disorders
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse effects of muscle relaxants
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Muscle Relaxant Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Muscle Relaxant Drugs Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3. Skeletal Muscle Relaxant Drugs
    • 5.3.1. Global Muscle Relaxant Drugs Market, by Skeletal Muscle Relaxant Drugs, by Region, 2019-2032 (USD Billion)
  • 5.4. Facial Muscle Relaxant Drugs
    • 5.4.1. Global Muscle Relaxant Drugs Market, by Facial Muscle Relaxant Drugs, by Region, 2019-2032 (USD Billion)
  • 5.5. Neuromuscular Blocking Agents
    • 5.5.1. Global Muscle Relaxant Drugs Market, by Neuromuscular Blocking Agents, by Region, 2019-2032 (USD Billion)

6. Global Muscle Relaxant Drugs Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Muscle Relaxant Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Injectable
    • 6.4.1. Global Muscle Relaxant Drugs Market, by Injectable, by Region, 2019-2032 (USD Billion)

7. Global Muscle Relaxant Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Muscle Relaxant Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Muscle Relaxant Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Muscle Relaxant Drugs Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.6. Diagnostic Labs
    • 7.6.1. Global Muscle Relaxant Drugs Market, by Diagnostic Labs, By Region, 2019-2032 (USD Billion)

8. Global Muscle Relaxant Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Muscle Relaxant Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Muscle Relaxant Drugs Market - North America
    • 8.3.1. North America: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.4. Muscle Relaxant Drugs Market - U.S.
      • 8.3.4.1. U.S.: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.5. Muscle Relaxant Drugs Market - Canada
      • 8.3.5.1. Canada: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.4. Muscle Relaxant Drugs Market - Europe
    • 8.4.1. Europe: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.4. Muscle Relaxant Drugs Market - UK
      • 8.4.4.1. UK: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.5. Muscle Relaxant Drugs Market - France
      • 8.4.5.1. France: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.6. Muscle Relaxant Drugs Market - Germany
      • 8.4.6.1. Germany: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.7. Muscle Relaxant Drugs Market - Italy
      • 8.4.7.1. Italy: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.8. Muscle Relaxant Drugs Market - Spain
      • 8.4.8.1. Spain: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.9. Muscle Relaxant Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.10. Muscle Relaxant Drugs Market - Russia
      • 8.4.10.1. Russia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.5. Muscle Relaxant Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.4. Muscle Relaxant Drugs Market - China
      • 8.5.4.1. China: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.5. Muscle Relaxant Drugs Market - India
      • 8.5.5.1. India: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.6. Muscle Relaxant Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.7. Muscle Relaxant Drugs Market - Japan
      • 8.5.7.1. Japan: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.8. Muscle Relaxant Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.9. Muscle Relaxant Drugs Market - South Korea
      • 8.5.9.1. South Korea: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.6. Muscle Relaxant Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.4. Muscle Relaxant Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.5. Muscle Relaxant Drugs Market - UAE
      • 8.6.5.1. UAE: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.6. Muscle Relaxant Drugs Market - Israel
      • 8.6.6.1. Israel: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.7. Muscle Relaxant Drugs Market - South Africa
      • 8.6.7.1. South Africa: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.7. Muscle Relaxant Drugs Market - Latin America
    • 8.7.1. Latin America: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.4. Muscle Relaxant Drugs Market - Mexico
      • 8.7.4.1. Mexico: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.5. Muscle Relaxant Drugs Market - Brazil
      • 8.7.5.1. Brazil: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.6. Muscle Relaxant Drugs Market - Argentina
      • 8.7.6.1. Argentina: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amneal Pharmaceuticals
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Drug Type Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Ipsen Biopharmaceuticals
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Drug Type Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Merz Pharmaceuticals
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Drug Type Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Par Pharmaceutical
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Drug Type Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Endo Pharmaceuticals
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Drug Type Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Vertical Pharmaceuticals
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Drug Type Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mallinckrodt
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Drug Type Benchmarking
    • 10.7.4. Recent Development
  • 10.8. SteriMax
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Drug Type Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Eisai Co.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Drug Type Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Metacel Pharmaceuticals
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Drug Type Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Metacel Pharmaceuticals
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Drug Type Benchmarking
    • 10.11.4. Recent Development

List of Tables

  • Table 1 Global Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 2 Global Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 3 Global Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Muscle Relaxant Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 6 North America: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 7 North America: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 10 U.S.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 Canada: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Europe: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 UK: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 19 UK: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 21 France: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 22 France: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 25 Germany: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Italy: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 31 Spain: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 37 Russia: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 42 China: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 China: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 45 India: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 46 India: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Japan: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 South Korea: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 67 UAE: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 70 Israel: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 South Africa: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 Latin America: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 79 Mexico: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 82 Brazil: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 85 Argentina: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Muscle Relaxant Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global Muscle Relaxant Drugs Market, by Route of Administration, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Muscle Relaxant Drugs Market, by Drug Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Muscle Relaxant Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Muscle Relaxant Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Muscle Relaxant Drugs Market